Does an increase of cyclic AMP prevent methamphetamine-induced behavioral sensitization in rats?

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 377-383

  Iyo, Masaomi ^a   Bi, Ying ^a   Hashimoto, Kenji ^a,b   Tomitaka, Shin Ichiro ^b   Inada, Toshiya ^a   Fukui, Susumu ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DOPAMINE; METHAMPHETAMINE; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; ETIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT; REARING; SENSITIZATION;

ANIMALIA;

EID: 0030464116     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17458.x     Document Type: Conference Paper

References (25)

1. RANDRUP, A. & I. MUNKVAD. 1970. Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine. In Amphetamines and Related Compounds. E. Costa & S. Garattini, Eds. 695-713. Raven Press. New York.
2. SEGAL, D. S. & A. J. MANDELL. 1974. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2: 249-255.
3. POST, R. M. & H. ROSE. 1976. Increasing effects of repetitive cocaine administration in the rat. Nature 260: 731-732.
4. NISHIKAWA, T., N. MATAGA, M. TAKASHIMA & M. TORU. 1983. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88: 190-203.
5. ROBINSON, T. E. & J. B. BECKER. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198.
6. KALIVAS, P. W. & J. STEWART. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244.
7. HENRY, D. J. & F. J. WHITE. 1991. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258: 882-890.
8. STEWART, J. & P. VEZINA. 1989. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495: 401-406.
9. VEZINA, P. & J. STEWART. 1989. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499: 108-120.
10. UJIKE, H., T. ONOUE, K. AKIYAMA, T. HAMAMURA & S. OTSUKI. 1989. Effects of selective D1 and D2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98: 89-92.
11. DREW, K. L. & S. D. GLICK. 1990. Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response. Psychopharmacology 101: 465-471.
12. KEBABIAN, J. W. & D. B. CALNE. 1979. Multiple receptors for dopamine. Nature 277: 93-96.
13. SEEMAN, P. 1980. Brain dopamine receptors. Pharmacol. Rev. 32: 229-213.
14. LOWE, J. A. III. & J. B. CHENG. 1992. The PDE IV family of calcium-independent phosphodiesterase enzymes. Drugs Future 17: 799-807.
15. WACHTEL, H. 1982. Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 77: 309-316.
16. SCHNEIDER, H. H., R. SCHMIECHEN, M. BREZINSKI & J. SEIDLER. 1986. Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur. J. Pharmacol. 127: 105-115.
17. STONE, E. A. & S. M. JOHN. 1992. Stress-induced increase of extracellular levels of cyclic AMP in rat cortex. Brain Res. 597: 144-147.
18. STOOF, J. C. & J. W. KEBABIAN. 1981. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366-368.
19. LAZARENO, S., D. B. MARRIOTT & S. R. NAHORSKI. 1985. Differential effect of selective and nonselective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices. Brain Res. 361: 91-98.
20. IYO, M., Y. MAEDA, T. INADA, Y. KITAO, H. SASAKI & S. FUKUI. 1995. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram on methamphetamine-induced behavior. Neuropsychopharmacology 13: 33-39.
21. ROBINSON, T. E., P. A. JURSON, J. A. BENNETT & K. M. BENTGEN. 1988. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462: 211-222.
22. KAZAHAYA, Y., K. AKIMOTO & S. OTSUKI. 1989. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol. Psychiatry 25: 903-912.
23. HAMMAMURA, T., K. AKIYAMA, K. AKIMOTO, K. KASHIHARA, K. OKUMURA, H. UJIKE & S. OTSUKI. 1991. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546: 40-46.
24. SEGAL, D. S. & R. KUCZENSKI. 1992. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571: 330-337.
25. UNDIE, A. S. & E. FRIEDMAN. 1994. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cAMP formation in brain slices. J. Neurochem. 63: 222-230.